Delivery Order SPE2DB20D9331-SPE2DB24FL0W8
Award Date 3/29/24
Potential Completion Date 4/19/24
Potential Value $3.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,210.96 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of TISSUEBLUE 0.025% SYRINGE 0.5ML, a specialized pharmaceutical product, with a period of performance through December 20, 2024. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $4,963.32 firm fixed-price delivery order is for the supply of TISSUEBLUE 0.025% SYRINGE 0.5ML medical products. The contract has an ultimate completion date of June 10, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,013.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 0.5 mL syringes containing 0.025% Tissue Blue solution. This order is issued against DMS Pharmaceutical's indefinite delivery contract SPE2DB valued at up to $4,999,999 through 2025, which enables DLA to procure a broad range of pharmaceutical products for...
- This federal contract award, valued at $1,654.44, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of TISSUEBLUE 0.025% SYRINGE 0.5ML, a medical product, with an ultimate completion date of August 6, 2025. The contract is a firm fixed-price delivery order, and there was no set-aside used. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in...
- This federal contract award, with ID SPE2DB20D9331 and SPE2DB23FL1M2, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,088.56 firm fixed-price delivery order is for the supply of TISSUEBLUE 0.025% SYRINGE 0.5ML, a pharmaceutical product, with a completion date of September 21, 2023. This award is part of a larger indefinite delivery contract (IDC) valued at up to...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $9,336.66, is for the provision of VABYSMO 6 MG/0.05 ML SYRINGE 0.05ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation, allowing DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,634.04 firm fixed-price delivery order is for the supply of VisionBlue 0.06% syringes with a 0.5ML capacity. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,654.44 to DMS Pharmaceutical Group Inc. on September 26, 2025, for the supply of Tissueblue 0.025% syringes in 0.5ml quantities. This firm fixed-price delivery order is scheduled for ultimate completion by October 20, 2025, with fulfillment from the vendor's location in Park Ridge, Illinois. The award did not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its...
- This federal contract award, valued at $2,451.06, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order to provide a specific pharmaceutical product, the VISIONBLUE 0.06% SYRINGE 0.5ML, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite...
- This federal contract award is for the delivery of TISSUEBLUE 0.025% SYRINGE 0.5ML medical supplies to the Department of Defense (DoD) healthcare system. The $2,481.66 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. DMS Pharmaceutical Group has a significant single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid...